Cargando…

Underweight is a major risk factor for atrial fibrillation in Asian people with type 2 diabetes mellitus

BACKGROUND: Atrial fibrillation (AF) is prevalent in patients with type 2 diabetes mellitus (T2DM). Obesity commonly accompanies T2DM, and increases the risk of AF. However, the dose-relationship between body mass index (BMI) and AF risk has seldom been studied in patients with diabetes. METHODS: Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hsu, Jung-Chi, Yang, Yen-Yun, Chuang, Shu-Lin, Chung, Yi-Wei, Wang, Chih-Hsien, Lin, Lian-Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613951/ https://www.ncbi.nlm.nih.gov/pubmed/34819090 http://dx.doi.org/10.1186/s12933-021-01415-2

Ejemplares similares

Higher long-term visit-to-visit glycemic variability predicts new-onset atrial fibrillation in patients with diabetes mellitus
por: Hsu, Jung-Chi, et al.
Publicado: (2021)

Glycemic status and risks of thromboembolism and major bleeding in patients with atrial fibrillation
por: Chan, Yi-Hsin, et al.
Publicado: (2020)

Long Term Outcome of Postoperative Atrial Fibrillation After Cardiac Surgery—A Propensity Score-Matched Cohort Analysis
por: Hsu, Jung-Chi, et al.
Publicado: (2021)

Prognostic significance of diabetes mellitus in patients with atrial fibrillation
por: Papazoglou, Andreas S., et al.
Publicado: (2021)

Associations of anemia with death and major bleeding in patients with atrial fibrillation: A report from the Chinese Atrial Fibrillation Registry Study
por: Zhang, Zhuxin, et al.
Publicado: (2021)

Effectiveness, safety, and major adverse limb events in atrial fibrillation patients with concomitant diabetes mellitus treated with non-vitamin K antagonist oral anticoagulants
por: Chan, Yi-Hsin, et al.
Publicado: (2020)

Catheter Ablation With Morphologic Repetitiveness Mapping for Persistent Atrial Fibrillation
por: Lin, Chin-Yu, et al.
Publicado: (2023)

Comparison of Clinical Outcomes Among Patients With Atrial Fibrillation or Atrial Flutter Stratified by CHA(2)DS(2)-VASc Score
por: Lin, Yu-Sheng, et al.
Publicado: (2018)

Real‐World Rivaroxaban and Apixaban Levels in Asian Patients With Atrial Fibrillation
por: Lin, Shin‐Yi, et al.
Publicado: (2019)

Prediabetes as a risk factor for new-onset atrial fibrillation: the propensity-score matching cohort analyzed using the Cox regression model coupled with the random survival forest
por: Hsu, Jung-Chi, et al.
Publicado: (2023)

Four‐year incidence of major adverse cardiovascular events in patients with atherosclerosis and atrial fibrillation
por: Miao, Benjamin, et al.
Publicado: (2020)

Connexin 43 is involved in the sympathetic atrial fibrillation in canine and canine atrial myocytes
por: Shu, Chenglin, et al.
Publicado: (2017)

Rivaroxaban Monotherapy for Atrial Fibrillation and Coronary Artery Disease in Underweight/Obese Patients: Evidence Is Needed
por: Zhou, Dao, et al.
Publicado: (2022)

Sex, age, type of diabetes and incidence of atrial fibrillation in patients with diabetes mellitus: a nationwide analysis
por: Bisson, Arnaud, et al.
Publicado: (2021)

The impact of weight loss related to risk of new-onset atrial fibrillation in patients with type 2 diabetes mellitus treated with sodium–glucose cotransporter 2 inhibitor
por: Chan, Yi-Hsin, et al.
Publicado: (2021)

Underweight in the First 2 Years of Life and Growth in Later Childhood
por: South, Courtney A., et al.
Publicado: (2022)

Catheter ablation in Asian patients with atrial fibrillation and hypertrophic cardiomyopathy: electrophysiological characteristics of recurrence and long-term clinical outcomes
por: Lin, Chih-Hsien, et al.
Publicado: (2023)

Risk of atrial fibrillation in patients with pneumoconiosis: A nationwide study in Taiwan
por: Hu, Wei‐Syun, et al.
Publicado: (2019)

Atrial fibrillation and its arrhythmogenesis associated with insulin resistance
por: Chan, Yi-Hsin, et al.
Publicado: (2019)

Efficacy of Cryoballoon Ablation for Atrial Fibrillation and Recurrence Predictors in an Asian Cohort
por: Wu, Shang-Ju, et al.
Publicado: (2022)

The risk of new-onset atrial fibrillation in patients with type 2 diabetes mellitus treated with sodium glucose cotransporter 2 inhibitors versus dipeptidyl peptidase-4 inhibitors
por: Ling, Ann Wan-Chin, et al.
Publicado: (2020)

Safety and efficacy of ablation for atrial fibrillation in combination with left atrial appendage occlusion in octogenarians
por: Zhang, Peng‐Pai, et al.
Publicado: (2023)

Left atrial appendage size is a marker of atrial fibrillation recurrence after radiofrequency catheter ablation in patients with persistent atrial fibrillation
por: Simon, Judit, et al.
Publicado: (2021)

Relationship between diabetes mellitus and atrial fibrillation prevalence in the Polish population: a report from the Non-invasive Monitoring for Early Detection of Atrial Fibrillation (NOMED-AF) prospective cross-sectional observational study
por: Gumprecht, Jakub, et al.
Publicado: (2021)

Being Underweight Is Associated with Increased Risk of Sudden Cardiac Death in People with Diabetes Mellitus
por: Kim, Yun Gi, et al.
Publicado: (2023)

Predictive value of HMGB1 for atrial fibrillation recurrence after cryoballoon ablation in paroxysmal atrial fibrillation patients
por: Li, Xinxin, et al.
Publicado: (2022)

Intracardiac versus transesophageal echocardiography for diagnosis of left atrial appendage thrombosis in atrial fibrillation: A meta‐analysis
por: He, Guijun, et al.
Publicado: (2021)

Long‐Term Visit‐to‐Visit Glycemic Variability as a Predictor of Major Adverse Limb and Cardiovascular Events in Patients With Diabetes
por: Hsu, Jung‐Chi, et al.
Publicado: (2023)

Incidence and risk factors of atrial fibrillation in Asian COPD patients
por: Liao, Kuang-Ming, et al.
Publicado: (2017)

Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non–vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage
por: Tsai, Chuan-Tsai, et al.
Publicado: (2020)

Increased small extracellular vesicle levels and decreased miR‐126 levels associated with atrial fibrillation and coexisting diabetes mellitus
por: Siwaponanan, Panjaree, et al.
Publicado: (2023)

Racial/Ethnic and Socioeconomic Disparities in Management of Incident Paroxysmal Atrial Fibrillation
por: Eberly, Lauren A., et al.
Publicado: (2021)

Initial rivaroxaban dosing in patients with atrial fibrillation
por: Ablefoni, Kaja, et al.
Publicado: (2019)

Age at Diagnosis of Atrial Fibrillation and Incident Dementia
por: Zhang, Wenya, et al.
Publicado: (2023)

Underweight predicts extubation failure after planned extubation in intensive care units
por: Chuang, Chung-Yeh, et al.
Publicado: (2023)

Epidemiological characteristics, management, and outcomes of atrial fibrillation in TUNISIA: Results from the National Tunisian Registry of Atrial Fibrillation (NATURE‐AF)
por: Ouali, Sana, et al.
Publicado: (2021)

Gene Expression Networks in the Murine Pulmonary Myocardium Provide Insight into the Pathobiology of Atrial Fibrillation
por: Boutilier, Jordan K., et al.
Publicado: (2017)

High variability in bodyweight is associated with an increased risk of atrial fibrillation in patients with type 2 diabetes mellitus: a nationwide cohort study
por: Lee, Hyun-Jung, et al.
Publicado: (2020)

Factors Associated With Child Stunting, Wasting, and Underweight in 35 Low- and Middle-Income Countries
por: Li, Zhihui, et al.
Publicado: (2020)

Newly Diagnosed Atrial Fibrillation Is an Independent Factor for Future Major Adverse Cardiovascular Events
por: Li, Chen-Yu, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_vlii91nfh0e8pp29ea7omld5fd